Company Information

Medafor, Inc. develops and markets an innovative breakthrough in hemostatic technology and absorbable hemostats called Microporous Polysaccharide Hemospheres (MPH^®). Based in Minneapolis, Minnesota, Medafor’s management and employees have significant experience working in the highly regulated global medical device and biotech community. 

About Arista^®AH

Microporous Polysaccharide Hemospheres (MPH^®) rapidly dehydrate blood and accelerate the body’s natural blood clotting process. The MPH Technology is marketed worldwide under the brand name Arista^®AH.

Mechanism of Action